Tianjin Chase Sun Pharmaceutical Co Ltd
SZSE:300026
Tianjin Chase Sun Pharmaceutical Co Ltd
Revenue
Tianjin Chase Sun Pharmaceutical Co Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Tianjin Chase Sun Pharmaceutical Co Ltd
SZSE:300026
|
Revenue
¥6.1B
|
CAGR 3-Years
-2%
|
CAGR 5-Years
8%
|
CAGR 10-Years
11%
|
|
H
|
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
|
Revenue
¥10.1B
|
CAGR 3-Years
5%
|
CAGR 5-Years
6%
|
CAGR 10-Years
N/A
|
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
|
Revenue
¥9.7B
|
CAGR 3-Years
14%
|
CAGR 5-Years
16%
|
CAGR 10-Years
22%
|
|
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
|
Revenue
¥22.3B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
7%
|
CAGR 10-Years
14%
|
|
Yunnan Baiyao Group Co Ltd
SZSE:000538
|
Revenue
¥39.1B
|
CAGR 3-Years
6%
|
CAGR 5-Years
8%
|
CAGR 10-Years
9%
|
|
C
|
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
|
Revenue
¥2.5B
|
CAGR 3-Years
24%
|
CAGR 5-Years
15%
|
CAGR 10-Years
N/A
|
See Also
What is Tianjin Chase Sun Pharmaceutical Co Ltd's Revenue?
Revenue
6.1B
CNY
Based on the financial report for Dec 31, 2023, Tianjin Chase Sun Pharmaceutical Co Ltd's Revenue amounts to 6.1B CNY.
What is Tianjin Chase Sun Pharmaceutical Co Ltd's Revenue growth rate?
Revenue CAGR 10Y
11%
Over the last year, the Revenue growth was -8%. The average annual Revenue growth rates for Tianjin Chase Sun Pharmaceutical Co Ltd have been -2% over the past three years , 8% over the past five years , and 11% over the past ten years .